The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Electrochemotherapy: Aspects of Preclinical Development and Early Clinical Experience
Open accessAbstract
OBJECTIVE: To develop an optimized, reproducible system of electrochemotherapy, and to investigate its clinical application in patients with cutaneous or subcutaneous recurrences of inoperable or progressive disease recalcitrant to current anticancer treatments. BACKGROUND: Electrochemotherapy is the application of electric pulses to tumor tissue, rendering the cell membranes permeable to otherwise impermeant or poorly permeant anticancer drugs. This facilitates a potent local cytotoxic effect. STUDY DESIGN: The optimal parameters for electrical pulses and bleomycin concentration were obtained in vitro and then applied to tumors derived from 4 histologically distinct human cancer cell lines (7860, PC3, OE19, MCF-7) established in athymic nude mice. Comparison was made with tumors that received bleomycin alone, electric pulses alone, and untreated controls. The optimized electrochemotherapy was then applied to patients with cutaneous or subcutaneous tumors, of any histologic type, recurrent or metastatic and unresponsive to standard chemotherapy and/or radiotherapy regimens. Tumors were assessed at monthly intervals to determine response to the treatment. RESULTS: In vivo: Using the optimal parameters ascertained in vitro, all tumors treated by electrochemotherapy with bleomycin (n = 24) had significantly regressed (P < 0.001, all 4 lines) compared with control tumors (n = 72). Twelve tumors completely regressed (50%) following a single application, with 12 partial regressions (50%). Clinical: In 30 patients (111 tumors), none of the treated tumors progressed. Sixty percent of tumors (66 of 111) showed complete regression, 22% (24 of 111) partial response, and 18% (21 of 111) no change. Electrochemotherapy was more effective in smaller tumors (<3 cm), 71% (64 of 90) showing complete regression, 20% (18 of 90) partial response, and 9% (8 of 90) no change. CONCLUSIONS: Electrochemotherapy parameters optimized in vitro are applicable in vivo. This treatment is effective in athymic nude mice for all histologic types indicating a nonimmunologic mode of action. In clinical application, electrochemotherapy is an effective, safe, and reproducible therapy. Patients with cutaneous or subcutaneous tumors previously refractory to surgical intervention, systemic chemotherapy, and/or radiotherapy responded successfully irrespective of histologic type.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Langer, R. (1990) · Science · doi:10.1126/science.2218494 · Cited by 1,778
Cited by
Antitumor effectiveness of electrochemotherapy: A systematic review and meta-analysis
Mali, B., Jarm, T., Snoj, M., Sersa, G., & Miklavcic, D. (2013) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2012.08.016 · Cited by 353
Campana, L. G., Mocellin, S., Basso, M., Puccetti, O., De Salvo, G. L., Chiarion-Sileni, V., Vecchiato, A., Corti, L., Rossi, C. R., & Nitti, D. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0204-8 · Cited by 291
Metadata
- Authors
- Larkin, J. O., Collins, C. G., Aarons, S., Tangney, M., Whelan, M., O??Reily, S., Breathnach, O., Soden, D. M., & O??Sullivan, G. C.
- Venue
- Annals of Surgery
- Published
- 2007-03
- Volume
- 245
- Issue
- 3
- Pages
- 469-479
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W1970207102
- Cited by
- 170
- References
- 1
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Electrochemotherapy: Aspects of Preclinical Development and Early Clinical Experience. https://app.cochat.ai/papers/10.1097/01.sla.0000250419.36053.33
- The paper
- Larkin, J. O., Collins, C. G., Aarons, S., Tangney, M., Whelan, M., O??Reily, S., Breathnach, O., Soden, D. M., & O??Sullivan, G. C. (2007). Electrochemotherapy: Aspects of Preclinical Development and Early Clinical Experience. Annals of Surgery. https://doi.org/10.1097/01.sla.0000250419.36053.33
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.